REVIVAL OF THALIDOMIDE From tragedy to promise Dr.J.Thirunavukkarasu M.D History of Thalidomide • 1954: synthesized • 1956: introduced and marketed as a nonbarbiturate…

Cincinnati Path 1-26 Pamela Norden, MD 01/2006 2nd Edition 01/2007 O. Aspen, MD 1. Accessory Tragus Accessory Tragus Polypoid Lesion Central focus of superficial fat Occassional…

1. Bone Marrow Transplant 2. Types of Transplant • Autologous (your own cells) • Allogeneic – cells from another person • Sibling • Unrelated Donor • Parent or…

1. Fundamental of Mesenchymal StemCells as a promising candidate inregenerative medicine(The International Journal of Biochemistry & Cell Biology) 2. Adult Stem Cells•…

Slide 1PAST EVENTS GUIDES CONFLICTS OF INTEREST TODAY Prof Rohini Fernandopulle Slide 2 Cancer research hospital Seattle 1981 – 1993 Researchers - trying to reduce graft…

1.NIH Public Access Author Manuscript Expert Rev Hematol. Author manuscript; available in PMC 2011 April 1. Published in final edited form as:NIH-PA Author ManuscriptExpert…

1.APPLIED ANATOMY OF DIGESTIVE SYSTEM BY- UNDER THE GUIDANCE OF ASMA MAZGAONKAR DR. SIPPY SIR SHADAB KHAN ASHISH UBALE JITENDRA MOURYA NARENDRA DAUNDKAR VINOD DARADE PREETI…

1.APPLIED ANATOMY OF DIGESTIVE SYSTEMBYASMA MAZGAONKAR SHADAB KHAN ASHISH UBALE JITENDRA MOURYA NARENDRA DAUNDKAR VINOD DARADE PREETI TAWDEUNDER THE GUIDANCE OF DR. SIPPY…

1. Alterative Donor HSCT Now Everyone Has a Donor Richard Champlin, M.D. 2. Donor Priority • HLA matched sibling • HLA matched unrelated donor • Alternative Donor –One…

1. By: Dr. Vahid NikouiEmail: [email protected] 2. *Milstein & Kohler in 1975*Hybridoma*Antibody-forming cells fused to immortal plasmacytoma cells*Hybrid cells…